Skip to content
MarketScale
‹ Back to IndustriesHealthcare

The Future of Fiber Optics Is Looking Bright

What kind of industry could potentially have a compound annual growth rate (CAGR) of around 9% over the next decade? The answer: the global fiber optics market. That would mean by 2025, the fiber optic market could be worth approximately $7.52 billion. There is little question that the future is looking bright for fiber optics….

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

What kind of industry could potentially have a compound annual growth rate (CAGR) of around 9% over the next decade? The answer: the global fiber optics market. That would mean by 2025, the fiber optic market could be worth approximately $7.52 billion. There is little question that the future is looking bright for fiber optics.

What will drive all of this growth? The primary mainspring is the need for high bandwidth in the maritime environment, the healthcare industry, technological advancements, and upgrades to current systems. Increasing demand for high-speed internet is driving the demand for high-speed fiber optics systems, including higher-capacity optical fibers and system components like optical amplifiers. Everyone wants more bandwidth, and fiber optics is proving it can deliver.

Fiber Optics, VDSL, and Home Demand for High-Speed Internet

Rising internet speeds has led to an increase in demand for Fiber to the Home (FTTH). If anything can slow the growth of fiber optics, though, it’s competition from the latest development in DSL to VDSL. Glass and plastic optical fibers are competing against copper wire, but with the rising prices of copper, it is likely that fiber optics will remain competitive.

Temperature Sensors

One place where fiber optics remains vital is the temperature sensors market. This market is expected to grow by nearly 6% over the next five years, from $5.62 billion in 2018 to $7.48 billion in 2023. Growth is expected from their use in the chemical, consumer electronics (like wearables and smartphones), oil and gas, energy and power, and automotive industries.

Optical Amplifiers

Optical amplifiers are a central component to fiber optics systems, and as the demand for fiber optics increases, so will demand for optical amplifiers. In fact, it’s predicted that the optical amplifier market will grow by around $936 million between 2019 and 2023, averaging a 9% CAGR that keeps step with the projected 9% growth for fiber optical systems. Long- and ultra-long-haul (from cities to continents) networks that amplify signal transmission over long distances will likely be a key growth driver in this sector.

Let Fiberguide Industries Be Your Guide to a Fiber Optical Future

For more than three decades, Fiberguide Industries has been a reliable, long-term strategic partner with OEM manufacturers in providing efficient, cost-effective, practical fiber optic solutions engineered to meet their specific needs. Specializing in manufacturing large core specialty optical fiber and high temperature metalized optical fibers, Fiberguide packages their fibers in a variety of assemblies/bundles to meet the requirements of diverse optical power delivery and optical sensing applications. With corporate headquarters and fiber manufacturing located in Stirling, New Jersey, applications engineering, component, and assembly manufacturing in Caldwell, Idaho, and a sales office and manufacturing in Shanghai, China, Fiberguide Industries is well positioned to serve the needs of their customers globally.

To learn more about how Fiberguide can help guide you to better optical fiber solutions, contact us at https://www.fiberguide.com/ today!

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly has broken ground on a $6.5 billion manufacturing facility in Houston, slated for completion around 2030. While attention has focused on scaling production of Foundayo, its oral GLP-1 treatment, the project also reflects broader U.S. efforts to rebuild domestic pharmaceutical manufacturing and highlights the supply chain challenge of forecasting demand and building capacity years in advance.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain, making it difficult to commit billions to manufacturing capacity years before demand and required output are clear.
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

NextGen Invent’s Deepak Mittal argues for scoped healthcare AI pilots with early governance

NextGen Invent’s Deepak Mittal argues that healthcare AI pilots can begin with a reliable data subset and early governance. His performance figures are vendor claims, not independently verified results.

  • 01Deepak Mittal advocates starting with a defined problem and suitable data rather than waiting for perfect organization-wide data.
  • 02Some performance figures cited in the interview (for example, preparation time and model counts) are company-reported and not independently verified in this article.
  • 03NIST’s voluntary AI Risk Management Framework provides an independent structure for governance and risk evaluation.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512